
NVO
Healthcare · Drug Manufacturers - General · $183.52B market cap
$41.63+0.98 (+2.4%)Nov 13, 4:25 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +10.0% over 90 days · 30-day revisions 2 up, 1 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 4, 2026 | Before the open | 0.81 | 0.89 | +9.9% |
| Aug 4, 2026 | After the close | 0.82 | 0.96 | +17.1% |
| May 5, 2026 | After the close | 6.96 | 6.63 | -4.7% |
| Feb 3, 2026 | After the close | 5.90 | 6.04 | +2.4% |
| Nov 5, 2025 | Before the open | 0.77 | 1.02 | +32.5% |
| Aug 6, 2025 | Before the open | 6.00 | 5.96 | -0.7% |
| May 7, 2025 | Before the open | 6.07 | 6.53 | +7.6% |
| Feb 4, 2025 | After the close | 5.97 | 6.34 | +6.2% |
| Nov 6, 2024 | Before the open | 5.92 | 6.12 | +3.4% |
| Aug 7, 2024 | Before the open | 0.74 | 0.66 | -10.4% |
| May 2, 2024 | Before the open | 0.77 | 0.83 | +7.8% |
| Jan 31, 2024 | Before the open | 0.66 | 0.71 | +7.6% |
| Nov 2, 2023 | Before the open | 0.69 | 0.73 | +5.8% |
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare…
| Aug 10, 2023 | Time not confirmed | 0.63 | 0.67 | +6.3% |
| May 4, 2023 | After the close | 0.61 | 0.63 | +3.3% |
| Feb 1, 2023 | Before the open | 0.43 | 0.41 | -5.3% |
| Nov 2, 2022 | Before the open | 0.42 | 0.43 | +2.6% |
| Aug 4, 2022 | Time not confirmed | 0.41 | 0.42 | +2.5% |
| Apr 28, 2022 | Time not confirmed | 0.42 | 0.47 | +11.0% |
| Feb 2, 2022 | Before the open | 0.36 | 0.36 | +1.0% |
| Nov 3, 2021 | Before the open | 0.39 | 0.42 | +8.1% |
| Aug 4, 2021 | After the close | 0.39 | 0.42 | +7.1% |
| May 5, 2021 | Before the open | 0.40 | 0.44 | +9.0% |
| Feb 3, 2021 | Before the open | 0.32 | 0.32 | -0.1% |
| Nov 3, 2020 | Time not confirmed | 0.32 | 0.34 | +9.5% |
| Aug 7, 2020 | Time not confirmed | 0.36 | 0.36 | -0.2% |
| May 5, 2020 | Time not confirmed | 0.34 | 0.37 | +5.9% |
| Feb 5, 2020 | Before the open | 0.28 | 0.27 | -2.7% |
| Nov 1, 2019 | Before the open | 0.30 | 0.32 | +5.1% |
| Aug 9, 2019 | Before the open | 0.30 | 0.30 | +0.8% |
| May 3, 2019 | Before the open | 0.30 | 0.33 | +7.1% |
| Feb 1, 2019 | Before the open | 0.27 | 0.27 | 0.0% |
| Nov 1, 2018 | Before the open | 0.28 | 0.29 | +0.2% |
| Aug 10, 2018 | Time not confirmed | 0.33 | 0.33 | +0.5% |
| May 2, 2018 | Before the open | 0.34 | 0.35 | +6.0% |
| Feb 1, 2018 | Before the open | 0.29 | 0.28 | -2.9% |